Peer-Reviewed
Publications
As part of our commitment to clinical excellence, we conduct ongoing research and have published several peer-reviewed articles.
Peer-Reviewed
May 2023 - Addiction: Polydrug Use Among Patients on Methadone Medication Treatment: Evidence from Urine Drug Testing to Inform Patient Safety
Saloner B, Whitley P, Dawson E, Passik S, Gordon AJ, Stein BD. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety. Addiction. 2023. https:// doi.org/10.1111/add.16180
March 2023 - JAMA Psychiatry: Association of Patients’ Direct Addition of Buprenorphine to Urine Drug Test Specimens with Clinical Factors in Opioid Use Disorder
Pytell JD, Whitley P, Passik SD, Bundy WL, Dawson E, Saloner B. Association of Patients’ Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder. JAMA Psychiatry. 2023;80(5):459–467. doi:10.1001/jamapsychiatry.2023.0234
August 2022 - Journal of Opioid Management: Definitive Urine Drug Test Findings in Patients Prescribed Opioids for Pain from a Large National Database
Guevara M, LaRue L, Zacharoff, KL, Whitley P, Passik SD. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database. Journal of Opioid Management, 18(4), 361–375. doi.org/10.5055/jom.2022.0723
June 2022 - JAMA Network Open: Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020
Whitley P, LaRue L, Fernandez SA, et al. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020. JAMA Netw Open. 2022;5(6):e2215425.
October 2021 - Drug and Alcohol Dependence: Seasonal and Regional Influences on Alcohol Consumption: An Analysis of Near-Real-Time Urine Drug Test Results in Those Seeking Health Care
Olson KL, Whitley P, Velasco J, LaRue L, Dawson E, Huskey A. Seasonal and Regional Influences on Alcohol Consumption: An Analysis of Near-Real-Time Urine Drug Test Results in Those Seeking Health Care. Drug Alcohol Depend. 2021;227:108908. doi: 10.1016/j.drugalcdep.2021.108908.
September 2021 - JAMA Network Open: Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database
Saloner B, Whitley P, LaRue L, Dawson E, Huskey A. Polysubstance Use Among Patients Treated with Buprenorphine from a National Urine Drug Test Database. JAMA Netw Open. 2021; 4(8): e2123019. doi:10.1001/jamanetworkopen.2021.23019
December 2020 - Journal of Addiction Medicine: The Cyclical and Evolving Nature of Methamphetamine Use: An Evaluation of Near Real-Time Urine Drug Test Results
LaRue L, Guevara MG, Whitley P, Dawson E, Twillman RK, Huskey A. The Cyclical and Evolving Nature of Methamphetamine Use: An Evaluation of Near Real-Time Urine Drug Test Results [published online ahead of print December 8, 2020]. J Addict Med. doi: 10.1097/ADM.0000000000000778.
December 2020 - Drug and Alcohol Dependence: Fentanyl Analog Positivity Among Near-Real-Time Urine Drug Test Results in Patients Seeking Health Care
Stanton JD, Whitley P, LaRue L, Bundy WL, Dawson E, Huskey A. Fentanyl Analog Positivity Among Near-Real-Time Urine Drug Test Results in Patients Seeking Health Care. Drug Alcohol Depend. 2020;217:108264. doi: 10.1016/j.drugalcdep.2020.108264.
September 2020 - JAMA: Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak
Wainwright JJ, Mikre M, Whitley P, et al. Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak. JAMA. Published online September 18, 2020. doi:10.1001/jama.2020.17694
January 2020 - JAMA Network Open: Evaluation of Trends of Near-Real-Time Urine Drug Test Results for Methamphetamine, Cocaine, Heroin, and Fentanyl
Twillman RK, Dawson E, LaRue L et al. Evaluation of Trends of Near Real-Time Urine Drug Test Results for Cocaine, Methamphetamine, Heroin and Fentanyl. JAMA Netw Open. 2020;3(1):e1918514. doi:10.1001/jamanetworkopen.2019.18514
April 2019 - JAMA Network Open: Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine
LaRue L, Twillman RK, Dawson E., et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open.2019;2(4):e192851. Doi:10.1001/jamanetworkopen.2019.2851
December 2018 - Drug and Alcohol Dependence: Positivity Rates of Drugs in Patients Treated for Opioid Dependence with Buprenorphine: A comparison of oral fluid and urine using pair collections and LC-MS/MS
West R, Mikel C, Hofilena D, et al. Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS. Drug Alcohol Depend. 2018; 193:183-191.
June 2017 - Journal of Opioid Management: Detection of Naltrexone and Naltrexol in Urine of Patients Prescribed Embeda®
West R, Guevara M, Mikel C. Detection of naltrexone and naltrexol in patients prescribed Embeda®. J Opioid Manag. May/June 2017; 13(3): 139-40.
February 2017 - Therapeutic Drug Monitoring: Detection of Hydrocodone and Morphine as Metabolites in Oral Fluid by LC-MS/MS in Patients Prescribed Codeine
West RE, Guevara MG, Mikel C, et al. Detection of hydrocodone and morphine as metabolites in oral fluid by LC-MS/MS in patients prescribed codeine. Ther Drug Monit. 2017 Feb; 39(1): 88-90.
December 2016 - Journal of Addiction Medicine: Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes
Rzetelny A, Zeller B, Miller N, et al. Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report. J Addict Med. 2016;10(6):443-447.
July 2015 - International Journal of Mental Health and Addiction: Counselors’ Clinical Use of Definitive Drug Testing Results in Their Work with Substance-Use Clients
Rzetelny A, Zeller B, Miller N, et al. Counselors’ Clinical Use of Definitive Drug Testing Results in Their Work with Substance-Use Clients: a Qualitative Study. Int J Ment Health Addict. 2016;14:64-80.
Contact Us
Patient Billing
(877) 451-7337
Monday-Friday 6:00AM-4:00PM PT
Corporate Headquarters
(877) 451-3534
